Adicet Bio, Inc. — Director's Dealing 2022

Mar 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2022-03-09

Reporting Person: Jakobovits Aya (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-09	Common Stock	S	2000	$14.00	Disposed	356343	Indirect
2022-03-09	Common Stock	S	2000	$14.00	Disposed	356345	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	138076	Indirect

Footnotes

F1: These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.

F2: Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary.

F3: Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary.

F4: Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.